Swiss All Share Index
18.184,13
PKT
+479,41
PKT
+2,71
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu Swiss All Share Index-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 21.10.16 | Roche Hold | Kepler Cheuvreux | |
| 21.10.16 | Nestlé buy | Kepler Cheuvreux | |
| 21.10.16 | Nestlé overweight | Barclays Capital | |
| 21.10.16 | Zurich Insurance overweight | Barclays Capital | |
| 21.10.16 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 21.10.16 | Zurich Insurance overweight | JP Morgan Chase & Co. | |
| 21.10.16 | Nestlé Hold | Baader Wertpapierhandelsbank | |
| 21.10.16 | UBS buy | HSBC | |
| 21.10.16 | Roche Hold | HSBC | |
| 21.10.16 | Nestlé Hold | HSBC | |
| 20.10.16 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 20.10.16 | UBS Underweight | JP Morgan Chase & Co. | |
| 20.10.16 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 19.10.16 | UBS Neutral | Seaport Global Securities | |
| 19.10.16 | Roche Outperform | Bernstein Research | |
| 19.10.16 | Novartis Outperform | Bernstein Research | |
| 19.10.16 | Novartis Underweight | Morgan Stanley | |
| 19.10.16 | Zurich Insurance Equal-Weight | Morgan Stanley | |
| 19.10.16 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 19.10.16 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 19.10.16 | ABB (Asea Brown Boveri) Neutral | Goldman Sachs Group Inc. | |
| 17.10.16 | Nestlé overweight | Morgan Stanley | |
| 17.10.16 | Givaudan buy | Deutsche Bank AG | |
| 17.10.16 | Holcim buy | Deutsche Bank AG | |
| 17.10.16 | Zurich Insurance Neutral | UBS AG | |
| 17.10.16 | Zurich Insurance Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 14.10.16 | Novartis Hold | Deutsche Bank AG | |
| 14.10.16 | UBS Outperform | Cowen and Company, LLC | |
| 14.10.16 | Swiss Re buy | Deutsche Bank AG | |
| 14.10.16 | Nestlé buy | Goldman Sachs Group Inc. | |
| 13.10.16 | Zurich Insurance overweight | JP Morgan Chase & Co. | |
| 13.10.16 | Swiss Re overweight | JP Morgan Chase & Co. | |
| 13.10.16 | Roche overweight | Morgan Stanley | |
| 13.10.16 | Novartis buy | Jefferies & Company Inc. | |
| 13.10.16 | Roche buy | Jefferies & Company Inc. | |
| 13.10.16 | ABB (Asea Brown Boveri) Sell | Citigroup Corp. | |
| 12.10.16 | Givaudan buy | Baader Wertpapierhandelsbank | |
| 12.10.16 | Roche buy | Deutsche Bank AG | |
| 12.10.16 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
| 11.10.16 | Givaudan overweight | JP Morgan Chase & Co. |